David A. Siegel Eton Pharmaceuticals, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 100,900 shares of ETON stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,900
Previous 53,100
90.02%
Holding current value
$1.87 Million
Previous $689,000
108.56%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ETON
# of Institutions
90Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$53.1 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$37.7 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$24.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$21.8 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$11 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $470M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...